基因组不稳定性衍生基因作为肺腺癌的新预后特征
Xu Zhang1, Tak-Wah Lam1, Hing-Fung Ting1
1Department of Computer Science, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Frontiers in cell and developmental biology
|September 1, 2023
概括
研究人员使用基因组不稳定性相关基因识别了GULPsig,这是肺腺癌的新型预后签名. 这种特征有助于对患者进行分层,并改善肺癌的生存预测.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 癌症生物标志物 癌症生物标志物
背景情况:
- 肺腺癌的发病率正在上升,但预后结果和生存率仍然有限.
- 基因组不稳定是癌症进展的关键因素,使瘤存活和转移.
- 很少有研究研究了基因组不稳定性在肺腺癌预后中的作用.
研究的目的:
- 为了确定与肺腺癌中的基因组不稳定性相关的预后特征.
- 为了验证识别的签名的性能和临床实用性.
主要方法:
- 利用癌症基因组图谱数据库,将397名肺腺癌患者分为训练和测试组.
- 通过比较高和低基因组变异组之间的基因表达,确定了与基因组不稳定性相关的基因.
- 采用考克斯回归,卡普兰-梅尔分析和时间依赖的ROC分析来识别和验证签名.
主要成果:
- 确定了包括5个基因 (IGF2BP1,IGF2BP3,SMC1B,CLDN6,LY6K) 的GULPsig,作为肺腺癌的预后特征.
- 成功地将患者分为高风险和低风险组,使用GULPsig风险评分.
- 与已建立的相比,GULPsig作为一个独立的预后签名表现出了卓越的性能.
结论:
- GULPsig为肺腺癌中基因组不稳定性的临床应用提供了新的见解.
- 对于肺腺癌患者来说,GULPsig 是一个有希望的预后签名,有可能改善临床管理.
更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.1K
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
9.0K
相关概念视频
Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
Cancer-Critical Genes I: Proto-oncogenes
9.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Loss of Tumor Suppressor Gene Functions
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
